Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.

Scientific reports - 27 Apr 2021

Yan Dan, Chen Yi

Abstract excerpt

Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the mechanisms of LUSC and develop a model to predict the overall survival of LUSC patients. The information of patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carcinoma, Squamous Cell
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Biological

Share to Nomograms

Share to Predictive Value of Tests

Share to Prognosis

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 33907270
DOI: 10.1038/s41598-021-88694-7
PMCID: PMC8079676

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.PMID 33907270Read ↗

Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinomaSemantic proximity Read ↗

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity Read ↗

Machine learning analysis of lung squamous cell carcinoma gene expression datasets reveals novel prognostic signaturesSemantic proximity Read ↗

Identification of seven-gene signature for prediction of lung squamous cell carcinomaSemantic proximity Read ↗

Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA dataSemantic proximity Read ↗

A prognostic 4-gene expression signature for squamous cell lung carcinoma.Semantic proximity Read ↗

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics AnalysisSemantic proximity Read ↗

Identification of key genes associated with progression and prognosis for lung squamous cell carcinomaSemantic proximity Read ↗

Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinomaSemantic proximity Read ↗

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.Semantic proximity Read ↗

Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity Read ↗

Exploration of Tumor Mutation Burden Combined with Immune Infiltrates in the Prognosis of Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.